WO2025094139 - SIMULTANEOUS DETECTION OF MULTIPLE ALZHEIMER BIOMARKERS
National phase entry is expected:
Publication Number
WO/2025/094139
Publication Date
08.05.2025
International Application No.
PCT/IB2024/060827
International Filing Date
01.11.2024
Title **
[English]
SIMULTANEOUS DETECTION OF MULTIPLE ALZHEIMER BIOMARKERS
[French]
DÉTECTION SIMULTANÉE DE MULTIPLES BIOMARQUEURS D'ALZHEIMER
Applicants **
MARA NANOTECH, INC.
Inventors
LEE, HeaYeon
Priority Data
63/595,331
01.11.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5404 | |
| EPO | Filing, Examination, Granting | 133580 | |
| Japan | Filing, Examination, Granting | 5083 | |
| South Korea | Filing, Examination, Granting | 6415 | |
| USA | Filing, Examination, Granting | 26740 |
Total:
177,222
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
This application is directed to detecting presence or quantity of at least two different molecules. A sensor includes a plurality of chambers, a nanowell array electrode, and a circuit board platform. The sensor separates, cleaves, filters, and detects the at least two different molecules selected from the group consisting of Aβ peptides and tau-protein from a sample in the plurality of nanowells. In some embodiments, the presence or quantity of at least three different Aβ peptides is detected, and an effective amount of a therapeutic compound is administrated to treat Alzheimer in a subject in need thereof.[French]
La présente invention concerne la détection de la présence ou de la quantité d'au moins deux molécules différentes. Un capteur comprend une pluralité de chambres, une électrode à réseau de nanopuits et une plateforme de carte de circuit imprimé. Le capteur sépare, clive, filtre et détecte les au moins deux molécules différentes choisies dans le groupe constitué de peptides Aβ et de protéine tau à partir d'un échantillon dans la pluralité de nanopuits. Dans certains modes de réalisation, la présence ou la quantité d'au moins trois peptides Aβ différents est détectée, et une quantité efficace d'un composé thérapeutique est administrée pour traiter la maladie d'Alzheimer chez un sujet en ayant besoin.